FDA approves new HIV treatment
The Food and Drug Administration announced that it had approved Gilead Sciences’ Genvoya (elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide, or E/C/F/TAF) to treat HIV. It is a complete regimen for the treatment of HIV-1 infection in adults and pediatric...
Posted On Nov 05 2015